Radiothérapie Moléculaire et Innovation Thérapeutique

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas et al. · Nature Medicine · 2022 · 642 citations · Full text

Medicine, Cancer Biology, Oncology +13

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome

Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva et al. · Cell · 2024 · 164 citations · Full text

Life Sciences, Immunology, Oncology +17

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells

Roger Sun, Nora Sundahl, Markus Hecht et al. · Journal for ImmunoTherapy of Cancer · 2020 · 96 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Yungan Tao, Xu-Shan Sun, Y. Pointreau et al. · European Journal of Cancer · 2023 · 54 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Radiomics to evaluate interlesion heterogeneity and to predict lesion response and patient outcomes using a validated signature of CD8 cells in advanced melanoma patients treated with anti-PD1 immunotherapy

Roger Sun, Marvin Lerousseau, Jade Briend-Diop et al. · Journal for ImmunoTherapy of Cancer · 2022 · 33 citations · Full text

Medicine, Immunology, Oncology +17